Menu

How Do the Invesco KBW Bank ETF (KBWB) and the State Street Regional Banking Fund ETF (KRE) Compare With Each Other? ↗

October 01, 2026

KBWB's concentrated portfolio of 26 major banks delivered 14.7% returns over one year, while KRE's broader 167-holding approach yielded 12.5%.

Here's What a $10,000 Investment in SpaceX Stock Could Be Worth in 2035 (Hint: It's a Lot) ↗

Topics ETFs

October 01, 2026

SpaceX stock has the potential to increase fivefold or more in the coming years.

The latest update from the company demonstrates that its end markets continue to strengthen.

Topics Artificial Intelligence

GE Vernova's CEO Just Delivered Great News to Shareholders ↗

October 01, 2026

Rivian Stock Is Going to $19 According to This Wall Street Analyst. Here's Why They May Be Right. ↗

September 30, 2026

Rivian has exposure both to mass market EVs and robotaxis.

The stock market is one of the best vehicles for building wealth.

How to Start Investing in 2026: The Growth Stock I'm Buying Before Year-End ↗

September 30, 2026

Morgan Stanley Investment Management Announces Liquidation of Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF (CDEI)

Topics Bonds ETFs Economy

September 30, 2026

From Morgan Stanley

Via Business Wire

3 Robotics Stocks to Buy That Aren't Tesla ↗

September 30, 2026

As is so often the case, the best opportunities are often hiding behind the headline name.

Joby Aviation's flying taxis are getting closer to reality, but the company still has a long road ahead.

Topics Artificial Intelligence Electric Vehicles

Joby Aviation: Bull vs. Bear ↗

September 30, 2026

The Stock Market Is Going to Soar, According to Wall Street. Here’s What Investors Should Do. ↗

September 30, 2026

The Wall Street consensus says the S&P 500 will advance 21% in the next year.

2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right. ↗

Topics Artificial Intelligence Bonds ETFs

September 29, 2026

This biotech player is firing on all cylinders.

Financial providers use their expertise in capital allocation and risk assessment to help facilitate economic growth while offering consumers and businesses ...

Topics Intellectual Property

3 Financials Stocks to Research Further

September 29, 2026

Eli Lilly's share price climb has decelerated in 2026.

Here's Where Wall Street Analysts See Eli Lilly's Share Price Going ↗

September 26, 2026

These stocks are poised for growth as hyperscaler capital spending grows into the trillions.

2 Data Center Stocks That Could Help Make You a Fortune ↗

September 26, 2026

Diamondback Energy shares fell after a Morgan Stanley downgrade and a large share block sale, but strong Q2 earnings and a persistent Middle East supply gap support a higher oil price floor.

Topics Artificial Intelligence

Oil May Be Stronger Than It Looks—And Diamondback Is on Sale ↗

September 25, 2026

The eVTOL Trade Has Been Deflating for Months. Here's the 1 Catalyst That Could Reverse It. ↗

Topics Artificial Intelligence Earnings Energy

September 25, 2026

Investors have grown skeptical of the sector, but that could change.

Ingersoll Rand (NYSE:IR) executives said improving demand in short-, medium- and long-cycle businesses, combined with investments in commercial capabilities and engineered solutions, supported a more...

Ingersoll Rand Sees Broad Demand Recovery, Long-Cycle Orders Accelerate ↗

September 25, 2026

There is reason to believe that SpaceX shares could climb meaningfully higher in the next few years.

Topics Artificial Intelligence

Here's What a $1,000 Investment in SpaceX Stock Could Be Worth in 5 Years ↗

September 24, 2026

What Happened? Shares of cybersecurity platform provider CrowdStrike (NASDAQ:CRWD) jumped 4.5% in the afternoon session as it broke out to a fresh 52-week hi...

Topics Artificial Intelligence Economy Initial Public Offering

Why CrowdStrike (CRWD) Stock Is Up Today

September 23, 2026

What Happened? Shares of cruise vacation company Royal Caribbean (NYSE:RCL) fell 3.9% in the afternoon session after the company said it will buy half of San...

Topics Artificial Intelligence Bonds

Why Royal Caribbean (RCL) Stock Is Down Today

September 23, 2026

ATI (NYSE:ATI) has transformed its portfolio toward aerospace and defense markets, with those end markets now representing about 70% of total revenue, President and CEO Kim Fields said during a Morgan...

ATI Targets $1.35B EBITDA Run Rate as Aerospace, Defense Near 70% of Sales ↗

September 23, 2026

The biotech's obesity drug candidate could make it easier for people who have recently lost weight to keep it off.

Topics Artificial Intelligence

One AI Agent, Two Verdicts: Muse Lifts the Nasdaq to a Record and Knocks the Banks ↗

September 23, 2026

Via Chartmill

Topics Artificial Intelligence

Why Viking Therapeutics Stock Skyrocketed on Tuesday ↗

September 23, 2026

Neurocrine Biosciences (NASDAQ:NBIX) outlined its commercial growth priorities, pricing considerations and pipeline plans during a Morgan Stanley discussion, with CEO Kyle Gano emphasizing the...

Neurocrine Maps AI, China and Pipeline Strategy as INGREZZA Faces 2029 Price Hit ↗

September 23, 2026

LPL Financial, Northern Trust, Ameriprise Financial, Morgan Stanley, and Paymentus Stocks Trade Down, What You Need To Know

Topics Artificial Intelligence

September 22, 2026

What Happened? A number of stocks fell in the afternoon session after investors kept bidding the group lower after last week’s Federal Reserve hike. On Septe...

Compass Pathways (NASDAQ:CMPS) expects to complete its new drug application submission for COMP360, its investigational psilocybin treatment for treatment-resistant depression, in the fourth quarter,...

Topics Economy

Compass Pathways Eyes 2027 COMP360 Launch as FDA Review Advances ↗

September 22, 2026

There's a strong possibility the defense and aerospace giant's backlog will grow even more in the near future.

Topics Cannabis Government

Great News for RTX Investors (Hint: It Relates to Its Record $289 Billion Backlog) ↗

September 22, 2026

There are no AI data centers without copper.

Freeport-McMoRan's Low-Cost Secret to Take Advantage of Record Copper Prices ↗

September 22, 2026

Abeona Therapeutics (NASDAQ:ABEO) executives outlined the early commercial rollout of ZEVASKYN, an autologous cell sheet-based gene therapy for recessive dystrophic epidermolysis bullosa (RDEB), during...

Topics Artificial Intelligence

Abeona Expands ZEVASKYN Network as RDEB Launch Gains Momentum ↗

September 22, 2026